eSight Logo

eSight for
Vision Professionals

Man looking at prescription bottle

eSight is a proven digital device for patients with central vision loss

eSight is a clinically validated, FDA- and EUDAMED-registered digital low vision Class 1 medical device designed to help your patients with significant central vision loss and legal blindness enhance their vision.  

Backed by 10 years of research and development, eSight uses a compact, high-speed, high-definition camera to capture the patient’s visual field, while proprietary software algorithms optimize and enhance the footage presented to the user.¹

View Clinical Data
Refer a Patient

Conditions

eSight technology provides unprecedented improvement in a wide range of visual performance measures for more than 20 different eye conditions associated with central vision loss. eSight can immediately improve central vision for people who have moderate-to-severe visual impairment resulting from a variety of conditions, including*:

  • Age-related macular degeneration
  • Stargardt disease
  • Myopic macular degeneration
  • Diabetic retinopathy
  • Cone & rod dystrophy
  • And many more

* eSight may not be for patients who have dementia, glaucoma, or other neurogenerative diseases. 

Learn More About eSight Go

eSight eyewear significantly improves distance acuity

Distance Acuity Chart

Figure 1. Distance acuity equivalent of print size correctly read on the ETDRS chart at baseline without the device, at fitting with the device, and after 3 months of device use. Mean baseline acuity without device was 20/177 (mean logMAR, 0.95 [SD, 0.25]), which improved to 20/32 (mean, 0.20 [SD, 0.31]) with the device but stayed unchanged after 3 months of device use and training (mean, 0.19 [SD, 0.30]). *Statistically significant differences. ETDRS = Early Treatment Diabetic Retinopathy Study.

eSight eyewear significantly improves reading acuity

Reading Acuity Chart

Figure 2. Reading acuity equivalent of print size read on the MNREAD chart at baseline without the device, at fitting with the device, and after 3 months of device use. Mean baseline reading acuity without device was 20/159 (mean logMAR, 0.90 [SD, 0.34]), which improved to 20/43 (mean, 0.33 [SD, 0.39]) with the device but stayed unchanged after 3 months of device use and training (mean, 0.24 [SD, 0.36]). *Statistically significant differences.

Clinically Validated Results (eQUEST, ClinicalTrials.gov Identifier NCT02616900)

Independent studies of use of eSight by six renowned low vision institutions demonstrated:

  • A seven-line gain in distance acuity
  • 12 letter contrast improvement
  • 100% mobility retention
  • Significant increase in facial recognition
    Read eQuest Study
    Girl giving thumbs up using eSight 4

    Our eQuest Partners

    University of Montreal
    UHN
    University of Michigan
    Center for Retina & Macular Disease
    Johns Hopkins University

    eSight TeleHealth—A Remote Training Program For Your Patients

    The eSight TeleHealth program is proven to significantly improve patient quality of life through multiple peer-reviewed randomized controlled trials (RCT).

    The feasibility RCT demonstrated:

    • High accessibility with 93% of patients accessing the platform
    • Only 14% requiring assistance from friends or family
    • Minor technical issues with no cause for withdrawal
    • Global acceptability with 100% overall satisfaction reported
      Learn more about our TeleHealth Program
      Girl giving thumbs up using eSight 4

      Restore Their Independence

      Your patients are living with more than just vision loss. Provide the help your patients need to live the life they have been afraid of losing.

      • Gain up to 7 lines of distance visual acuity & 12 letters of contrast¹
      • Maintain mobility for independent living¹
      • All day wearability—lightweight and comfortable design
      • Allows users to move seamlessly through daily life
      • Ability to see faces of loved ones, read books, watch TV
      How It Works

      Testimonials

      eSight removes the traditional barriers people living with low vision face. Significantly enhancing sight while retaining mobility, eSight makes it possible for people with legal blindness to advance in all levels of school, achieve their professional goals, and more easily participate in society.

      Dr. Scott Gartner
      Low Vision Specialist, Lighthouses for the Blind, Palm Beaches and Miami

      eSight provides unprecedented improvement in a number of visual performance measures. This device has a substantial impact on the lives of many people with severe vision loss.

      Dr. Gislin Dagnelie, MS, PhD
      Associate Director, Lions Vision Research and Rehabilitation Center
      Associate Professor of Ophthalmology, Johns Hopkins Medicine Health Network

      eSight resulted in immediate improvements in all visual function measures, with activities of daily living showing improvement with training. Self-reported outcomes suggest that visual abilities are greatly improved when wearing the device.

      Dr. Walter Wittich
      PhD, Professor of Neuroscience, University of Montreal

      We have been so happy working with eSight. The whole approach of the company is very much about taking good care of the patient. This starts with a well designed device that is easy for patients to use while doing their every day activities. Their patient support program is excellent - patients have enough training to use the device adeptly for their lifestyles. We have no reservations referring our patients as we know they will be well cared for.

      Dr. Namrata Nandakumar, MD, Ophthamologist
      Retina Consultants of Boston

       

      Reference:1 . Wittich, W., Lorenzini, M.-C., Markowitz, S. N., Tolentino, M., Gartner, S. A., Goldstein, J. E., & Dagnelie, G. (2018). The Effect of a Head-mounted Low Vision Device on Visual Function. Optometry and Vision Science: Official Publication of the American Academy of Optometry, 95(9), 774–784. https://doi.org/10.1097/ OPX.0000000000001262.